Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 3, 2008 - Issue 12
Submit an article Journal homepage
49
Views
0
CrossRef citations to date
0
Altmetric
Perspectives

Can in vitro assessment provide relevant end points for cognitive drug programs?

Benedict C Albensi University of Manitoba, Department of Pharmacology & Therapeutics; St. Boniface Research Centre, Division of Neurodegenerative Disorders, 351 Tache Ave./Lab 4050 Winnipeg, Manitoba, R2H 2A6, Canada +1 204/235 3942; +1 204/237 4092; [email protected]; University of Manitoba, Centre on Ageing; Manitoba Institute Child Health (MICH), Health Sciences Center
, PhD (Assistant Professor, Department of Pharmacology & Therapeutics, Associate Professor, Application Pending, Principal Investigator – St. Boniface Research Centre)
Pages 1377-1382 | Published online: 01 Dec 2008

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.